Allergan Urges 1st Circ. To Reverse Asacol Class Cert.
Allergan PLC urged the First Circuit on Friday to reverse the certification of a class of buyers of an anti-inflammatory drug, accusing the putative class of "bootstrapping" claims from purchasers of...To view the full article, register now.
Already a subscriber? Click here to view full article